BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 15686598)

  • 21. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
    Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
    Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A local mechanism mediates NAD-dependent protection of axon degeneration.
    Wang J; Zhai Q; Chen Y; Lin E; Gu W; McBurney MW; He Z
    J Cell Biol; 2005 Aug; 170(3):349-55. PubMed ID: 16043516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calpains mediate axonal cytoskeleton disintegration during Wallerian degeneration.
    Ma M; Ferguson TA; Schoch KM; Li J; Qian Y; Shofer FS; Saatman KE; Neumar RW
    Neurobiol Dis; 2013 Aug; 56():34-46. PubMed ID: 23542511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WldS mice are resistant to paclitaxel (taxol) neuropathy.
    Wang MS; Davis AA; Culver DG; Glass JD
    Ann Neurol; 2002 Oct; 52(4):442-7. PubMed ID: 12325073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signaling mechanisms regulating Wallerian degeneration.
    Freeman MR
    Curr Opin Neurobiol; 2014 Aug; 27():224-31. PubMed ID: 24907513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering.
    Avery MA; Rooney TM; Pandya JD; Wishart TM; Gillingwater TH; Geddes JW; Sullivan PG; Freeman MR
    Curr Biol; 2012 Apr; 22(7):596-600. PubMed ID: 22425157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
    J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced oligodendrocyte survival after spinal cord injury in Bax-deficient mice and mice with delayed Wallerian degeneration.
    Dong H; Fazzaro A; Xiang C; Korsmeyer SJ; Jacquin MF; McDonald JW
    J Neurosci; 2003 Sep; 23(25):8682-91. PubMed ID: 14507967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further studies on motor and sensory nerve regeneration in mice with delayed Wallerian degeneration.
    Brown MC; Perry VH; Hunt SP; Lapper SR
    Eur J Neurosci; 1994 Mar; 6(3):420-8. PubMed ID: 8019679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Death Receptor 6 Promotes Wallerian Degeneration in Peripheral Axons.
    Gamage KK; Cheng I; Park RE; Karim MS; Edamura K; Hughes C; Spano AJ; Erisir A; Deppmann CD
    Curr Biol; 2017 Mar; 27(6):890-896. PubMed ID: 28285993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic influences on cellular reactions to spinal cord injury: a wound-healing response present in normal mice is impaired in mice carrying a mutation (WldS) that causes delayed Wallerian degeneration.
    Zhang Z; Fujiki M; Guth L; Steward O
    J Comp Neurol; 1996 Jul; 371(3):485-95. PubMed ID: 8842901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene.
    Mack TG; Reiner M; Beirowski B; Mi W; Emanuelli M; Wagner D; Thomson D; Gillingwater T; Court F; Conforti L; Fernando FS; Tarlton A; Andressen C; Addicks K; Magni G; Ribchester RR; Perry VH; Coleman MP
    Nat Neurosci; 2001 Dec; 4(12):1199-206. PubMed ID: 11770485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal axotomy.
    Adalbert R; Nógrádi A; Szabó A; Coleman MP
    Eur J Neurosci; 2006 Oct; 24(8):2163-8. PubMed ID: 17074042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential sprouting responses in axonal fiber systems in the dentate gyrus following lesions of the perforant path in WLDs mutant mice.
    Shi B; Stanfield BB
    Brain Res; 1996 Nov; 740(1-2):89-101. PubMed ID: 8973802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temperature modulation reveals three distinct stages of Wallerian degeneration.
    Tsao JW; George EB; Griffin JW
    J Neurosci; 1999 Jun; 19(12):4718-26. PubMed ID: 10366605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses.
    Adalbert R; Gillingwater TH; Haley JE; Bridge K; Beirowski B; Berek L; Wagner D; Grumme D; Thomson D; Celik A; Addicks K; Ribchester RR; Coleman MP
    Eur J Neurosci; 2005 Jan; 21(1):271-7. PubMed ID: 15654865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity.
    Antenor-Dorsey JA; O'Malley KL
    Mol Neurodegener; 2012 Feb; 7():5. PubMed ID: 22315973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anterograde-propagation of axonal degeneration in the visual system of wlds mice characterized by diffusion tensor imaging.
    Sun SW; Nishioka C; Chung CF; Park J; Liang HF
    J Magn Reson Imaging; 2017 Feb; 45(2):482-491. PubMed ID: 27373882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective strategies in MS: lessons from C57BL/Wld(S) mice.
    Coleman MP; Adalbert R; Beirowski B
    J Neurol Sci; 2005 Jun; 233(1-2):133-8. PubMed ID: 15899498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elimination of motor nerve terminals in neonatal mice expressing a gene for slow wallerian degeneration (C57Bl/Wlds).
    Parson SH; Mackintosh CL; Ribchester RR
    Eur J Neurosci; 1997 Aug; 9(8):1586-92. PubMed ID: 9283813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.